Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children

NCT01982396 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

NETWORK

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: ABC Twice Daily
DRUG: ABC Once Daily
DRUG: 3TC Once Daily
DRUG: 3TC Twice Daily

Sponsor

PENTA Foundation